CompX International Inc. (CIX)
USD 26.29
(-0.68%)
USD 26.29
(-0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 25.81 Million | 16.89 Million | 10.47 Million | 15.5 Million | 18.46 Million | 17.16 Million |
| Net Income | 22.59 Million | 20.87 Million | 16.56 Million | 10.32 Million | 15.99 Million | 15.32 Million |
| Depreciation & Amortization | 3.97 Million | 3.97 Million | 3.83 Million | 3.82 Million | 3.68 Million | 3.45 Million |
| Deferred income taxes | -720 Thousand | -688 Thousand | -321 Thousand | -48 Thousand | 89 Thousand | 86 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.44 Million | -7.48 Million | -9.88 Million | 1.05 Million | -1.76 Million | -1.99 Million |
| Other non-cash items | -280 Thousand | 213 Thousand | 269 Thousand | 346 Thousand | 458 Thousand | 289 Thousand |
| Investing Cash Flow | 1.14 Million | -31.09 Million | 6.7 Million | -3.14 Million | 2.85 Million | 1.08 Million |
| Investments in PPE | -1.13 Million | -3.69 Million | -4.09 Million | -1.74 Million | -3.16 Million | -3.11 Million |
| Acquisitions | - | 133 Thousand | 2000.00 | - | 125 Thousand | - |
| Investment purchases | -36.32 Million | -33.03 Million | - | - | - | - |
| Sales/Maturities of investments | 36 Million | -133 Thousand | - | - | - | - |
| Other Investing Activities | 2.6 Million | 5.63 Million | 10.8 Million | -1.4 Million | 5.9 Million | 4.2 Million |
| Financing Cash Flow | -12.31 Million | -35.62 Million | -11.24 Million | -4.98 Million | -3.48 Million | -2.48 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -12.31 Million | -33.88 Million | -9.92 Million | -4.98 Million | -3.48 Million | -2.48 Million |
| Common Stock Repurchased | - | -1.74 Million | -1.31 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -1.74 Million | -1.31 Million | - | - | - |
| Accounts receivables | 764 Thousand | -2.3 Million | -4.8 Million | 1.11 Million | 250 Thousand | -1.7 Million |
| Accounts payables | 104 Thousand | 943 Thousand | 2.54 Million | 95 Thousand | -399 Thousand | 1.77 Million |
| Inventory | 333 Thousand | -5.83 Million | -7.47 Million | -193 Thousand | -1.43 Million | -1.84 Million |
| Other working capital | 245 Thousand | -284 Thousand | -143 Thousand | 34 Thousand | -176 Thousand | -207 Thousand |
| Cash at beginning of period | 26.74 Million | 76.57 Million | 70.63 Million | 63.25 Million | 45.41 Million | 29.65 Million |
| Cash at end of period | 41.39 Million | 26.74 Million | 76.57 Million | 70.63 Million | 63.25 Million | 45.41 Million |
| Capital Expenditure | -1.13 Million | -3.69 Million | -4.09 Million | -1.74 Million | -3.16 Million | -3.11 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 14.64 Million | -49.83 Million | 5.94 Million | 7.38 Million | 17.84 Million | 15.75 Million |
| Free Cash Flow | 24.68 Million | 13.19 Million | 6.38 Million | 13.76 Million | 15.29 Million | 14.04 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.84 Million | 3.75 Million | 6.69 Million | 22.59 Million | 5.75 Million | 4.07 Million |
| Depreciation & Amortization | 920 Thousand | 926 Thousand | 977 Thousand | 3.97 Million | 987 Thousand | 999 Thousand |
| Deferred income taxes | -219 Thousand | -151 Thousand | -164 Thousand | -720 Thousand | -135 Thousand | -171 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.29 Million | -2.56 Million | 6.94 Million | 1.44 Million | -4.16 Million | 2.09 Million |
| Other non-cash items | -3.56 Million | 4.7 Million | -5.28 Million | -280 Thousand | -442 Thousand | -287 Thousand |
| Investing Cash Flow | 12.17 Million | 12.49 Million | 12.83 Million | 1.14 Million | 714 Thousand | -3.65 Million |
| Investments in PPE | -425 Thousand | -305 Thousand | -566 Thousand | -1.13 Million | -86 Thousand | -208 Thousand |
| Acquisitions | - | - | -294 Thousand | - | 86 Thousand | 208 Thousand |
| Investment purchases | - | - | 36.32 Million | -36.32 Million | -11.4 Million | -11.44 Million |
| Sales/Maturities of investments | 12 Million | 12 Million | 12 Million | 36 Million | 12 Million | 8 Million |
| Other Investing Activities | 600 Thousand | 799.99 Thousand | 1.4 Million | 2.6 Million | 114 Thousand | -208 Thousand |
| Financing Cash Flow | -3.69 Million | -3.69 Million | -3.07 Million | -12.31 Million | -3.07 Million | -3.07 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -3.69 Million | -3.69 Million | -3.07 Million | -12.31 Million | -3.07 Million | -3.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 14.16 Million | - | - | - | - |
| Accounts receivables | 1.89 Million | -264 Thousand | 2.66 Million | 764 Thousand | -4.69 Million | 3.63 Million |
| Accounts payables | 3.4 Million | -5.99 Million | 630 Thousand | 104 Thousand | 618 Thousand | 3.25 Million |
| Inventory | 94 Thousand | 3.1 Million | 3.53 Million | 333 Thousand | -614 Thousand | -3.59 Million |
| Other working capital | -1.09 Million | 583 Thousand | 123 Thousand | 245 Thousand | 524 Thousand | -1.2 Million |
| Cash at beginning of period | 51.86 Million | 41.39 Million | 17.59 Million | 26.74 Million | 17.95 Million | 17.98 Million |
| Cash at end of period | 70.17 Million | 51.86 Million | 41.39 Million | 41.39 Million | 17.59 Million | 17.95 Million |
| Capital Expenditure | -425 Thousand | -305 Thousand | -566 Thousand | -1.13 Million | -86 Thousand | -208 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 18.3 Million | 10.47 Million | 23.79 Million | 14.64 Million | -363 Thousand | -29 Thousand |
| Free Cash Flow | 9.4 Million | 1.36 Million | 13.47 Million | 24.68 Million | 1.91 Million | 6.49 Million |
ALL
JAYNECOIND
GAMI
SPECIALITY
PAG
LYKALABS